Inogen (INGN) Common Equity (2012 - 2026)

Inogen (INGN) has 15 years of Common Equity data on file, last reported at $182.9 million in Q1 2026.

• Common Equity for Q1 2026 came in at $182.9 million, down 7.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $182.9 million (down 7.6% YoY), and the FY2025 annual result was $192.2 million, up 10.57% from the prior year.
• Common Equity declined to $182.9 million in Q1 2026 per INGN's latest filing, from $192.2 million in the prior quarter.
• Over five years, Common Equity peaked at $358.3 million in Q1 2022 and troughed at $173.9 million in Q4 2024.
• A 5-year average of $239.0 million and a median of $199.5 million in 2025 frame the typical range for Common Equity.
• The sharpest annual moves came in 2023 and 2025: Common Equity sank 34.26% in 2023, then grew 10.57% in 2025.
• A 5-year view of Common Equity shows it stood at $297.4 million in 2022, then tumbled by 31.13% to $204.8 million in 2023, then dropped by 15.11% to $173.9 million in 2024, then gained by 10.57% to $192.2 million in 2025, then dropped by 4.85% to $182.9 million in 2026.
• Business Quant data shows INGN's Common Equity at $182.9 million in Q1 2026, $192.2 million in Q4 2025, and $197.2 million in Q3 2025.